Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Res Int ; 2021: 7300098, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34568494

RESUMO

This study reports the development of thermosensitive hydrogels for delivering ropivacaine (RVC), a wide clinically used local anesthetic. For this purpose, poloxamer- (PL-) based hydrogels were synthesized for evaluating the influence of polymer concentration, hydrophilic-lipophilic balances, and binary system formation on biopharmaceutical properties and pharmacological performance. Transition temperatures were shifted, and rheological analysis revealed a viscoelastic behavior with enhanced elastic/viscous modulus relationship (G'/G " = 1.8 to 22 times), according to hydrogel composition and RVC incorporation. The RVC release from PL407 and PL407/338 systems followed the Higuchi model (R 2 = 0.923-0.989), indicating the drug diffusion from hydrogels to the medium. RVC-PL hydrogels were potentially biocompatible evoking low cytotoxic effects (in fibroblasts and Schwann cells) and mild/moderate inflammation signs on sciatic nerve nearby histological evaluation. In vivo pharmacological assays demonstrated that PL407 and PL407/338 evoked differential analgesic effects, by prolonging the sensory blockade duration up to ~340 and 250 min., respectively. All those results highlighted PL407 and PL407/338 as promising new strategies for sustaining analgesic effects during the postoperative period.


Assuntos
Anestesia Local , Materiais Biocompatíveis/química , Hidrogéis/química , Poloxâmero/química , Ropivacaina/farmacologia , Células 3T3 , Analgesia , Animais , Área Sob a Curva , Varredura Diferencial de Calorimetria , Morte Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Liberação Controlada de Fármacos , Elasticidade , Masculino , Camundongos , Micelas , Ratos Wistar , Reologia , Nervo Isquiático/efeitos dos fármacos , Sensação/efeitos dos fármacos , Viscosidade
2.
J Nanobiotechnology ; 19(1): 30, 2021 Jan 22.
Artigo em Inglês | MEDLINE | ID: mdl-33482828

RESUMO

BACKGROUND: The advances in products based on nanotechnology have directed extensive research on low-cost, biologically compatible, and easily degradable materials. MAIN BODY: Sericin (SER) is a protein mainly composed of glycine, serine, aspartic acid, and threonine amino acids removed from the silkworm cocoon (particularly Bombyx mori and other species). SER is a biocompatible material with economic viability, which can be easily functionalized due to its potential crosslink reactions. Also, SER has inherent biological properties, which makes possible its use as a component of pharmaceutical formulations with several biomedical applications, such as anti-tumor, antimicrobials, antioxidants and as scaffolds for tissue repair as well as participating in molecular mechanisms attributed to the regulation of transcription factors, reduction of inflammatory signaling molecules, stimulation of apoptosis, migration, and proliferation of mesenchymal cells. CONCLUSION: In this review, the recent innovations on SER-based nano-medicines (nanoparticles, micelles, films, hydrogels, and their hybrid systems) and their contributions for non-conventional therapies are discussed considering different molecular mechanisms for promoting their therapeutic applications.


Assuntos
Materiais Biocompatíveis/química , Materiais Biocompatíveis/uso terapêutico , Nanoestruturas/química , Sericinas/química , Sericinas/uso terapêutico , Animais , Materiais Biocompatíveis/isolamento & purificação , Materiais Biocompatíveis/farmacologia , Bombyx/química , Sistemas de Liberação de Medicamentos/métodos , Humanos , Nanomedicina/métodos , Nanotecnologia/métodos , Sericinas/isolamento & purificação , Sericinas/farmacologia , Alicerces Teciduais/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...